Gastro Medical News about Liver Diseases

Your Unread Messages

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

New Model for End Stage Liver Disease Improves Prognostic Capability After Transjugular Intrahepatic Portosystemic Shunt
Clinical Gastroenterology and Hepatology , 11/05/09

Guy J et al. – MELDNa performed better than MELD in predicting death or transplant after non–emergent TIPS, especially in patients with low MELD scores. A MELD score <18 can provide a false positive prognosis; a MELDNa score <15 provides a more accurate risk prediction.

<< Previous
Impact Monitoring of the National Scale Up of Zinc Treatment for...

Next >>
Effect of Mild and Moderate Liver Disease on the Pharmacokinetics...

Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09 Relevance Score: 71%

Drinking Coffee Slows Progression Of Liver Disease In Chronic Hepatitis C Sufferers
ScienceDaily, 10/26/09 Relevance Score: 70%

Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers
EurekAlert, 10/21/09 Relevance Score: 70%

Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09 Relevance Score: 70%

Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
Antimicrobial Agents and Chemotherapy, 11/05/09 Relevance Score: 69%